165 related articles for article (PubMed ID: 14718373)
1. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of iduronic acid biosynthesis by ebselen reduces glycosaminoglycan accumulation in mucopolysaccharidosis type I fibroblasts.
Maccarana M; Tykesson E; Pera EM; Gouignard N; Fang J; Malmström A; Ghiselli G; Li JP
Glycobiology; 2021 Nov; 31(10):1319-1329. PubMed ID: 34192316
[TBL] [Abstract][Full Text] [Related]
3. [Mucopolysaccharidosis V (Ullrich-Scheie syndrome) (author's transl)].
Kovarik J; Vormittag W; Gebhart W; Ruthner U; Lubec G; Molzer B
Wien Klin Wochenschr; 1978 Dec; 90(23):839-44. PubMed ID: 154210
[TBL] [Abstract][Full Text] [Related]
4. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans.
Westergren-Thorsson G; Onnervik PO; Fransson LA; Malmström A
J Cell Physiol; 1991 Jun; 147(3):523-30. PubMed ID: 2066370
[TBL] [Abstract][Full Text] [Related]
6. Studies of cultured human fibroblasts in diabetes mellitus: changes in heparan sulfate.
Silbert CK; Kleinman HK
Diabetes; 1979 Jan; 28(1):61-4. PubMed ID: 153251
[TBL] [Abstract][Full Text] [Related]
7. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.
Hopwood JJ
Carbohydr Res; 1979 Mar; 69():203-16. PubMed ID: 106967
[TBL] [Abstract][Full Text] [Related]
8. [Alpha-L-iduronidase activity in fibroblasts of patients with Hurler syndrome].
Stareprawo G; Grimm U; Machill G; Knapp A; Wehnert M
Acta Biol Med Ger; 1975; 34(6):1079-82. PubMed ID: 812313
[No Abstract] [Full Text] [Related]
9. Fluorometric measurement of urinary alpha-L-iduronidase activity.
Isemura M; Kosaka H; Ikenaka T; Kido R; Yoshimura T
J Biochem; 1978 Sep; 84(3):627-32. PubMed ID: 102641
[TBL] [Abstract][Full Text] [Related]
10. Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.
Anson DS; Bielicki J; Hopwood JJ
Hum Gene Ther; 1992 Aug; 3(4):371-9. PubMed ID: 1525210
[TBL] [Abstract][Full Text] [Related]
11. Chemical definition of the mucopolysaccharidoses.
Constantopoulos G; Dekaban AS
Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of sulfate-containing acid mucopolysaccharides in I-cell fibroblasts.
Schmickel RD; Distler JJ; Jourdian GW
J Lab Clin Med; 1975 Oct; 86(4):672-82. PubMed ID: 170349
[TBL] [Abstract][Full Text] [Related]
13. Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts.
Klein U; Kresse H; von Figura K
Biochem Biophys Res Commun; 1976 Mar; 69(1):158-66. PubMed ID: 130905
[No Abstract] [Full Text] [Related]
14. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.
Dawes J; Pepper DS
Thromb Haemost; 1992 Apr; 67(4):468-72. PubMed ID: 1378652
[TBL] [Abstract][Full Text] [Related]
15. Beta-glucuronidase deficiency (mucopolysaccharidosis type VII).
Beaudet AL; Ferrante NM; Ferry GD; Nichols BL
Birth Defects Orig Artic Ser; 1974; 10(12):246-50. PubMed ID: 4218769
[No Abstract] [Full Text] [Related]
16. Inhibitors of dermatan sulfate epimerase 1 decreased accumulation of glycosaminoglycans in mucopolysaccharidosis type I fibroblasts.
Maccarana M; Li B; Li H; Fang J; Yu M; Li JP
Glycobiology; 2024 Apr; 34(6):. PubMed ID: 38760939
[TBL] [Abstract][Full Text] [Related]
17. Secondary storage of dermatan sulfate in Sanfilippo disease.
Lamanna WC; Lawrence R; Sarrazin S; Esko JD
J Biol Chem; 2011 Mar; 286(9):6955-62. PubMed ID: 21193389
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I).
Constantopoulos G; Shull RM; Hastings N; Neufeld EF
J Neurochem; 1985 Oct; 45(4):1213-7. PubMed ID: 3928817
[TBL] [Abstract][Full Text] [Related]
19. The mucopolysaccharidoses (a review).
Dorfman A; Matalon R
Proc Natl Acad Sci U S A; 1976 Feb; 73(2):630-7. PubMed ID: 813230
[TBL] [Abstract][Full Text] [Related]
20. Mucopolysaccharidosis in a domestic short-haired cat--a disease distinct from that seen in the Siamese cat.
Haskins ME; Jezyk PF; Desnick RJ; McDonough SK; Patterson DF
J Am Vet Med Assoc; 1979 Aug; 175(4):384-7. PubMed ID: 115818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
